|
1
|
Hazan RB and Norton L: The epidermal
growth factor receptor modulates the interaction of E-cadherin with
the actin cytoskeleton. J Biol Chem. 273:9078–9084. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheng CW, Wu PE, Yu JC, et al: Mechanisms
of inactivation of E-cadherin in breast carcinoma: modification of
the two-hit hypothesis of tumor suppressor gene. Oncogene.
20:3814–3823. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Berx G, Cleton-Jansen AM, Nollet F, et al:
E-cadherin is a tumour/invasion suppressor gene mutated in human
lobular breast cancers. EMBO J. 14:6107–6115. 1995.PubMed/NCBI
|
|
4
|
Vos CB, Cleton-Jansen AM, Berx G, et al:
E-cadherin inactivation in lobular carcinoma in situ of the breast:
an early event in tumorigenesis. Br J Cancer. 76:1131–1133. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoshida R, Kimura N, Harada Y and Ohuchi
N: The loss of E-cadherin, α- and β-catenin expression is
associated with metastasis and poor prognosis in invasive breast
cancer. Int J Oncol. 18:513–520. 2001.
|
|
6
|
Parker C, Rampaul RS, Pinder SE, et al:
E-cadherin as a prognostic indicator in primary breast cancer. Br J
Cancer. 85:1958–1963. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kowalski PJ, Rubin MA and Kleer CG:
E-cadherin expression in primary carcinomas of the breast and its
distant metastases. Breast Cancer Res. 5:R217–R222. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu JJ, Dang YY, Huang M, et al:
Anti-cancer properties of terpenoids isolated from Rhizoma
Curcumae - a review. J Ethnopharmacol. 143:406–411. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang G, Li X, Huang F, et al: Antitumor
effect of β-elemene in non-small-cell lung cancer cells is mediated
via induction of cell cycle arrest and apoptotic cell death. Cell
Mol Life Sci. 62:881–893. 2005.
|
|
10
|
Yao YQ, Ding X, Jia YC, et al: Anti-tumor
effect of β-elemene in glioblastoma cells depends on p38 MAPK
activation. Cancer Lett. 264:127–134. 2008.
|
|
11
|
Liu J, Zhang Y, Qu J, et al:
β-Elemene-induced autophagy protects human gastric cancer cells
from undergoing apoptosis. BMC Cancer. 11:1832011.
|
|
12
|
Li X, Wang G, Zhao J, et al:
Antiproliferative effect of β-elemene in chemoresistant ovarian
carcinoma cells is mediated through arrest of the cell cycle at the
G2-M phase. Cell Mol Life Sci. 62:894–904. 2005.
|
|
13
|
Chen W, Lu Y, Wu J, et al: Beta-elemene
inhibits melanoma growth and metastasis via suppressing vascular
endothelial growth factor-mediated angiogenesis. Cancer Chemother
Pharmacol. 67:799–808. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu Z, Wang R, Xu L, et al: β-Elemene
piperazine derivatives induce apoptosis in human leukemia cells
through downregulation of c-FLIP and generation of ROS. PLoS One.
6:e158432011.
|
|
15
|
Zhang B, Zhang X, Tang B, et al:
Investigation of elemene-induced reversal of tamoxifen resistance
in MCF-7 cells through oestrogen receptor α (ERα) re-expression.
Breast Cancer Res Treat. 136:399–406. 2012.PubMed/NCBI
|
|
16
|
Oesterreich S, Deng W, Jiang S, et al:
Estrogen-mediated down-regulation of E-cadherin in breast cancer
cells. Cancer Res. 63:5203–5208. 2003.PubMed/NCBI
|
|
17
|
Scherbakov AM, Andreeva OE, Shatskaya VA
and Krasil’nikov MA: The relationships between snail1 and estrogen
receptor signaling in breast cancer cells. J Cell Biochem.
113:2147–2155. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Horssen R, Hollestelle A, Rens JA, et
al: E-cadherin promotor methylation and mutation are inversely
related to motility capacity of breast cancer cells. Breast Cancer
Res Treat. 136:365–377. 2012.PubMed/NCBI
|
|
19
|
Foroni C, Broggini M, Generali D and Damia
G: Epithelial-mesenchymal transition and breast cancer: role,
molecular mechanisms and clinical impact. Cancer Treat Rev.
38:689–697. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nam JS, Ino Y, Kanai Y, et al:
5-aza-2′-deoxycytidine restores the E-cadherin system in
E-cadherin-silenced cancer cells and reduces cancer metastasis.
Clin Exp Metastasis. 21:49–56. 2004.
|
|
22
|
Peng G, Wargovich MJ and Dixon DA:
Anti-proliferative effects of green tea polyphenol EGCG on
Ha-Ras-induced transformation of intestinal epithelial cells.
Cancer Lett. 238:260–270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu Z, Ghosh S, Wang Z and Hunter T:
Downregulation of caveolin-1 function by EGF leads to the loss of
E-cadherin, increased transcriptional activity of beta-catenin, and
enhanced tumor cell invasion. Cancer Cell. 4:499–515. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mauro L, Pellegrino M, Lappano R, et al:
E-cadherin mediates the aggregation of breast cancer cells induced
by tamoxifen and epidermal growth factor. Breast Cancer Res Treat.
121:79–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Belguise K, Guo S and Sonenshein GE:
Activation of FOXO3a by the green tea polyphenol
epigallocatechin-3-gallate induces estrogen receptor α expression
reversing invasive phenotype of breast cancer cells. Cancer Res.
67:5763–5770. 2007.PubMed/NCBI
|
|
26
|
Helguero LA, Lindberg K, Gardmo C, et al:
Different roles of estrogen receptors α and β in the regulation of
E-cadherin protein levels in a mouse mammary epithelial cell line.
Cancer Res. 68:8695–8704. 2008.
|
|
27
|
Planas-Silva MD and Waltz PK: Estrogen
promotes reversible epithelial-to-mesenchymal-like transition and
collective motility in MCF-7 breast cancer cells. J Steroid Biochem
Mol Biol. 104:11–21. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cardamone MD, Bardella C, Gutierrez A, et
al: ERα as ligand-independent activator of CDH-1 regulates
determination and maintenance of epithelial morphology in breast
cancer cells. Proc Natl Acad Sci USA. 106:7420–7425. 2009.
|
|
29
|
Kumar R: Another tie that binds the MTA
family to breast cancer. Cell. 113:142–143. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fujita N, Kajita M, Taysavang P and Wade
PA: Hormonal regulation of metastasis-associated protein 3
transcription in breast cancer cells. Mol Endocrinol. 18:2937–2949.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mishra SK, Talukder AH, Gururaj AE, et al:
Upstream determinants of estrogen receptor-α regulation of
metastatic tumor antigen 3 pathway. J Biol Chem. 279:32709–32715.
2004.
|
|
32
|
Yu JC, Hsu HM, Chen ST, et al: Breast
cancer risk associated with genotypic polymorphism of the genes
involved in the estrogen-receptor-signaling pathway: a multigenic
study on cancer susceptibility. J Biomed Sci. 13:419–432. 2006.
View Article : Google Scholar
|
|
33
|
Toh Y and Nicolson GL: The role of the MTA
family and their encoded proteins in human cancers: molecular
functions and clinical implications. Clin Exp Metastasis.
26:215–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
